An alert on Danish drugmaker Curasight A/S CURAS.TE announcing successful dosing of a patient in its brain cancer drug trial was inadvertently tagged to U.S.-based Curis Inc CRIS.O, an unrelated entity, and has been withdrawn.
There will be no substitute
STORY_NUMBER:nTUA1WR1VX
STORY_DATE:18th December, 2025
STORY_TIME:06:46PM GMT
((Bangalore.newsroom@thomsonreuters.com))